Nahla M. Elsherbiny
- Hepatology top 10%
- Parasitology top 10%
-
- Antibiotic Resistance in Bacteria 4
-
- Antifungal resistance and susceptibility 2
- COVID-19 Clinical Research Studies 2
-
- Diabetes and associated disorders 3
-
- Gut microbiota and health 3
-
- Liver Disease Diagnosis and Treatment 2
-
- Nosocomial Infections in ICU 2
-
- Immune Cell Function and Interaction 2
- Co-authors
- Elham Ahmed HassanEnas DaefSahar M. HassanyHelal F. HettaMona SolimanA. M. MoharramMamdoh EskandarAsmaa M. Zahran
- Journals
- SHILAP Revista de lepidopterología (1 paper)Frontiers in Microbiology (1 paper)International Journal of Infectious Diseases (1 paper)
- Partner nations
- EgyptUnited StatesSaudi Arabia
In The Last Decade
Nahla M. Elsherbiny
20 papers receiving 317 citations
Peers
Comparison fields: 5 of 78
- Hepatology 79
- Applied Microbiology and Biotechnology 16
- Parasitology 37
- Molecular Medicine 27
- Infectious Diseases 92
Countries citing papers authored by Nahla M. Elsherbiny
This map shows the geographic impact of Nahla M. Elsherbiny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nahla M. Elsherbiny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nahla M. Elsherbiny more than expected).
Fields of papers citing papers by Nahla M. Elsherbiny
This network shows the impact of papers produced by Nahla M. Elsherbiny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nahla M. Elsherbiny. The network helps show where Nahla M. Elsherbiny may publish in the future.
Co-authorship network
The 19 scholars most cited alongside Nahla M. Elsherbiny, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2023 | 0 | |
| 3 | 2022 | 8 | |
| 4 | 2022 | 1 | |
| 5 | 2022 | 8 | |
| 6 | 2020 | 41 | |
| 7 | 2020 | 16 | |
| 8 | 2020 | 1 | |
| 9 | 2019 | 1 | |
| 10 | 2019 | 15 | |
| 11 | Frequency and Implications of Natural Killer and Natural Killer T Cells in Hepatocellular Carcinoma. | 2018 | 17 |
| 12 | Occult Hepatitis B Infection Among Blood Donors in Al Azhar University Hospital, Upper Egypt: The Current Status After 25 years of Vaccine Introduction. | 2018 | 4 |
| 13 | 2017 | 15 | |
| 14 | 2017 | 3 | |
| 15 | 2016 | 1 | |
| 16 | 2014 | 37 | |
| 17 | 2014 | 64 | |
| 18 | 2012 | 40 | |
| 19 | 2012 | 32 | |
| 20 | Clinical and Microbiological Profile of Nosocomial Infections in Adult Intensive Care Units at Assiut University Hospitals, Egypt | 2012 | 13 |
About Nahla M. Elsherbiny
Nahla M. Elsherbiny is a scholar working on Molecular Medicine, General Dentistry and Applied Microbiology and Biotechnology, having authored 21 papers that have together received 323 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (4 papers), Diabetes and associated disorders (3 papers), Gut microbiota and health (3 papers), Antifungal resistance and susceptibility (2 papers), Liver Disease Diagnosis and Treatment (2 papers), COVID-19 Clinical Research Studies (2 papers), Nosocomial Infections in ICU (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Hepatology (79 citations), Applied Microbiology and Biotechnology (16 citations) and Parasitology (37 citations). Nahla M. Elsherbiny has collaborated with scholars based in Egypt, United States and Saudi Arabia. Frequent co-authors include Elham Ahmed Hassan, Enas Daef, Sahar M. Hassany, Helal F. Hetta, Mona Soliman, A. M. Moharram, Mamdoh Eskandar, Asmaa M. Zahran, Amal Rayan and Azza Elkady. Their work appears in journals such as SHILAP Revista de lepidopterología, Frontiers in Microbiology and International Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.